Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Thomas, McNerney & Partners
1246
Thomas, McNerney & Partners
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development.
Suggest edits
Follow us
Overview
News
Investments
12
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
Invitae Stock Price: $48 Target By Oppenheimer
Pulse 2.0
Invitae Stock Price Increased Over 10% Pre-Market: Why It Happened
Xconomy
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx
the home of AI info
Invitae Acquires Diploid, Maker of Artificial–Intelligence Engine to Enable Clinical Diagnosis Using …
the home of AI info
Invitae Acquires Diploid, Maker of Artificial–Intelligence Engine to Enable Clinical Diagnosis Using …
PE HUB
Invitae to buy VC-backed Jungla
Xconomy
FDA Refuses to Review Zogenix Seizure Drug, Says File Not Complete
$70,000,000
Venture capital
Venture Funding News
Intuity Medical Obtains $70M in Funding
Acquisition
PE HUB
J&J's Ethicon acquires Torax Medical
Health
$20,000,000
Venture capital
silicontap
Intuity Medical Nabs $20M In Credit Line
Acquisition
Hot Stock Herald
,
StreetInsider.com
Invitae Expands Genome Network Via AltaVoice Acquisition
FinSMEs
Torax Medical Raises $25M in Series E Funding
Health
Funding
$25,000,000
Venture capital (Series E)
MassDevice
Torax Medical raises $25m
Xconomy
Invitae Scales Up DNA Test Offerings, Scores Mild Market Bump
Health
The Motley Fool
Zogenix, Inc. Shares Galloped 15% Higher in February -- Here's Why
Health
Stock markets
The Motley Fool
Zogenix, Inc Gained 29% in 2015 -- Here's Why --
Stock markets
The Motley Fool
Zogenix Zoomed Higher in November -- Here's Why --
Stock markets
Health
Earnings
